Health and Healthcare Research

Selected Research

• 

  Understanding the UK's pregnancy research needs and priorities

  A review of the research needs and expenditure on pregnancy in the UK found that £51 million is invested in pregnancy research each year. By contrast, the NHS spends £5.8 billion on pregnancy-related care each year and in 2018/19 litigation claims totalled £2.5 billion.

• 

  Economic benefits of malaria control

  Investing in malaria vaccination for children in sub-Saharan Africa not only helps in reducing malaria cases and deaths, it could also have long term macroeconomic benefits according to an economic model researchers developed.

• 

  Supporting the Asia's Healthiest Workplace Competition

  For three years, RAND Europe has supported AIA Vitality's contest. Doing so enables researchers to explore the health trends—employee lifestyle, clinical indicators, mental health and other areas of concern—among participating Asia-Pacific workplaces.

• 

  Britain's Healthiest Workplace survey findings

  Absence and presenteeism accounts for an average of 38 days' lost productivity per employee per year, marking an upward trend in lost productivity since 2014, when the number was only 23 days.

• 

  Understanding the societal burden of disease progression in multiple sclerosis

  MS is associated with high economic costs to society that go beyond the costs to the healthcare system, but researchers found limited evidence on the impact of disease progression on patients, carers, and society as a whole.

• 

  How does the pharmaceutical industry reuse health data?

  Several important factors can support or hinder the reuse of pharmaceutical data in the EU, including the availability, interoperability and quality of data; data analytic skills and experience; and the presence of clear and uniform regulations.

• 

  Supporting FasterCures' project on biomedical innovation metrics

  Researchers are helping FasterCures in their effort to understand the metrics that currently measure innovation in the biomedical ecosystem. They will also establish to what degree these existing approaches are appropriate and relevant to measure and drive innovation for the benefit of patients.

• 

  Evaluating the Wellbeing Premium Programme

  Small and medium enterprises (SMEs) often find it hard to invest in the health and wellbeing of their employees, or do not invest at all. Researchers are evaluating a randomised controlled trial of a financial incentive programme to improve employee health and wellbeing in SMEs in the West Midlands.